Sporadic primary malignant intracerebral nerve sheath tumors: case report and literature review

ZR Barnard, PK Agarwalla, DS Jeyaretna… - Journal of neuro …, 2011 - Springer
We report the case of a seventy-five year old woman with a sporadic primary malignant
intracerebral nerve sheath tumor (MINST). These tumors fall within the spectrum of …

Tissue microarrays: one size does not fit all

JE Eckel-Passow, CM Lohse, Y Sheinin, PL Crispen… - Diagnostic …, 2010 - Springer
Abstract Background Although tissue microarrays (TMAs) are commonly employed in clinical
and basic-science research, there are no guidelines for evaluating the appropriateness of a …

Tissue microarray-based evaluation of Chromatin Assembly Factor-1 (CAF-1)/p60 as tumour prognostic marker

M Mascolo, G Ilardi, F Merolla, D Russo… - International journal of …, 2012 - mdpi.com
In this study we aimed to confirm the emerging role of Chromatin Assembly Factor 1 (CAF-1
p60) as a new proliferation and prognostic marker for cancer and to test the usefulness of …

Evaluation of prognostic indicators using validated canine insulinoma tissue microarrays

FO Buishand, J Visser, M Kik, A Gröne, RI Keesler… - The Veterinary …, 2014 - Elsevier
Tissue microarray (TMA) technology allows analysis of multiple tumour samples
simultaneously on a single slide. The aim of the present study was to develop and assess a …

Comparison of TMA technique and routine whole slide analysis in evaluation of proliferative markers expression in laryngeal squamous cell cancer

U Ciesielska, A Piotrowska, C Kobierzycki… - in vivo, 2020 - iv.iiarjournals.org
Background/Aim: Comparison of the expression of Ki-67, MCM3, 5, 7 and MTI/II proteins
using immunohistochemistry (IHC) on whole section (WS) and tissue microarray (TMA) of …

Malignant peripheral nerve sheath tumors: clinicopathological aspects, expression of p53 and survival

KSG Cunha, AC Caruso, PAS de Faria, LE Silva… - Clinics, 2012 - SciELO Brasil
SciELO - Brasil - Malignant peripheral nerve sheath tumors: clinicopathological aspects,
expression of p53 and survival Malignant peripheral nerve sheath tumors …

[HTML][HTML] Evaluation of Bcl-2, Bcl-x and cleaved caspase-3 in malignant peripheral nerve sheath tumors and neurofibromas

KS Cunha, AC Caruso, PA Faria, LE SILVA… - Anais da Academia …, 2013 - SciELO Brasil
ABSTRACT AIMS To study the expression of Bcl-2, Bcl-x, as well the presence of cleaved
caspase-3 in neurofibromas and malignant peripheral nerve sheath tumors. The expression …

A clinicopathologic study on the role of estrogen, progesterone, and their classical and nonclassical receptors in cutaneous neurofibromas of individuals with …

RE Rozza-de-Menezes, LM Almeida… - American Journal of …, 2021 - academic.oup.com
Objectives To evaluate the expression of progesterone receptor (PR), estrogen receptor
(ER), and G protein–coupled estrogen receptor 1 (GPER-1) in cutaneous neurofibromas …

Immunohistochemical detectability of cyclooxygenase‐2 expression in cells of human melanocytic skin lesions: A methodological review

Ł Kuźbicki, AA Brożyna - Journal of Cutaneous Pathology, 2020 - Wiley Online Library
Abstract Increased cyclooxygenase‐2 (COX‐2) expression is thought to support
tumorigenesis through various mechanisms and is analyzed as a potential cancer marker. In …

Receptor of ghrelin is expressed in cutaneous neurofibromas of individuals with neurofibromatosis 1

RE Rozza-de-Menezes, NC Gaglionone… - Orphanet Journal of …, 2017 - Springer
Background Multiple cutaneous neurofibromas are a hallmark of neurofibromatosis 1 (NF1).
They begin to appear during puberty and increase in number and volume during pregnancy …